Literature DB >> 27624512

Lysosomal Acid Lipase Deficiency Unmasked in Two Children With Nonalcoholic Fatty Liver Disease.

Ryan W Himes1, Sarah E Barlow2, Kevin Bove3, Norma M Quintanilla4, Rachel Sheridan3, Rohit Kohli5.   

Abstract

Lysosomal acid lipase deficiency (LAL-D) is a classic lysosomal storage disorder characterized by accumulation of cholesteryl ester and triglyceride. Although it is associated with progressive liver injury, fibrosis, and end-stage liver disease in children and adolescents, LAL-D frequently presents with nonspecific signs that overlap substantially with other, more common, chronic conditions like nonalcoholic fatty liver disease (NAFLD), metabolic syndrome, and certain inherited dyslipidemias. We present 2 children with NAFLD who achieved clinically significant weight reduction through healthy eating and exercise, but who failed to have the anticipated improvements in aminotransferases and γ-glutamyl transferase. Liver biopsies performed for these "treatment failures" demonstrated significant microvesicular steatosis, prompting consideration of coexisting metabolic diseases. In both patients, lysosomal acid lipase activity was low and LIPA gene testing confirmed LAL-D. We propose that LAL-D should be considered in the differential diagnosis when liver indices in patients with NAFLD fail to improve in the face of appropriate body weight reduction.
Copyright © 2016 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2016        PMID: 27624512     DOI: 10.1542/peds.2016-0214

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

Review 1.  [Lysosomal acid lipase deficiency (LAL-D) : Diagnostic and therapeutic options in an underdiagnosed disease].

Authors:  S Synoracki; S Kathemann; K W Schmid; H Jastrow; H A Baba
Journal:  Pathologe       Date:  2018-05       Impact factor: 1.011

2.  Large-scale functional LIPA variant characterization to improve birth prevalence estimates of lysosomal acid lipase deficiency.

Authors:  Guillermo Del Angel; Andrew T Hutchinson; Nina K Jain; Chris D Forbes; John Reynders
Journal:  Hum Mutat       Date:  2019-07-12       Impact factor: 4.878

Review 3.  How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?

Authors:  Yana Geng; Klaas Nico Faber; Vincent E de Meijer; Hans Blokzijl; Han Moshage
Journal:  Hepatol Int       Date:  2021-02-06       Impact factor: 6.047

4.  Ameliorative effects of high intensity interval training and Lactobacillus rhamnosus GG Protect against tetracycline-induced fatty liver in rats: a gene expression profiling comparative study.

Authors:  Hamideh Mahmoodzadeh Hosseini; Hossein Shirvani; Fariba Aghaei; Ehsan Arabzadeh; Martin Hofmeister
Journal:  EXCLI J       Date:  2022-07-21       Impact factor: 4.022

5.  Fatty Liver Caused by Glycogen Storage Disease Type IX: A Small Series of Cases in Children.

Authors:  Catarina Leuzinger Dias; Inês Maio; José Ricardo Brandão; Edite Tomás; Esmeralda Martins; Ermelinda Santos Silva
Journal:  GE Port J Gastroenterol       Date:  2019-03-14

Review 6.  Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents.

Authors:  Daisuke Tokuhara
Journal:  Front Nutr       Date:  2021-06-25

Review 7.  Lysosomal acid lipase deficiency in pediatric patients: a scoping review.

Authors:  Camila da Rosa Witeck; Anne Calbusch Schmitz; Júlia Meller Dias de Oliveira; André Luís Porporatti; Graziela De Luca Canto; Maria Marlene de Souza Pires
Journal:  J Pediatr (Rio J)       Date:  2021-05-06       Impact factor: 2.990

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.